{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:37:47Z","timestamp":1793461067780,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institutes on Drug Abuse","doi-asserted-by":"crossref","award":["R01DA024598"],"award-info":[{"award-number":["R01DA024598"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institutes on Drug Abuse","doi-asserted-by":"crossref","award":["R01DA033862"],"award-info":[{"award-number":["R01DA033862"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH T32","award":["TL1RR033172"],"award-info":[{"award-number":["TL1RR033172"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.drugpo.2017.05.045","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T02:30:57Z","timestamp":1498185057000},"page":"86-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Healthcare contact and treatment uptake following hepatitis C virus screening and counseling among rural Appalachian people who use drugs"],"prefix":"10.1016","volume":"47","author":[{"given":"Dustin B.","family":"Stephens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April M.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Havens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugpo.2017.05.045_bib0005","series-title":"Recommendations for testing, managing, and treating hepatitis C","author":"AASLD-IDSA","year":"2016"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.045_bib0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2307\/270718","article-title":"Discrete-time methods for the analysis of event histories","volume":"13","author":"Allison","year":"1982","journal-title":"Sociological Methodology"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0015","series-title":"An analysis of mental health and substance abuse disparities & access to treatment services in the Appalachian region","author":"Appalachian Regional Commission","year":"2008"},{"issue":"9","key":"10.1016\/j.drugpo.2017.05.045_bib0020","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.socscimed.2011.02.015","article-title":"Does geographic access to primary healthcare influence the detection of hepatitis C?","volume":"72","author":"Astell-Burt","year":"2011","journal-title":"Social Science & Medicine"},{"issue":"11","key":"10.1016\/j.drugpo.2017.05.045_bib0025","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/cncr.20261","article-title":"Use of information resources by patients with cancer and their companions","volume":"100","author":"Basch","year":"2004","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.drugpo.2017.05.045_bib0030","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.drugpo.2007.01.013","article-title":"Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: A comprehensive approach","volume":"18","author":"Birkhead","year":"2007","journal-title":"International Journal on Drug Policy"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0035","series-title":"Beshear says more than 413,000 Kentuckians signed up for health care in state exchange","author":"Brammer","year":"2014"},{"issue":"RR-19","key":"10.1016\/j.drugpo.2017.05.045_bib0040","first-page":"1","article-title":"Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","journal-title":"MMWR Recommendations and Reports"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0045","series-title":"Viral hepatitis surveillance\u2014United States, 2014","author":"Centers for Disease Control and Prevention","year":"2016"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.045_bib0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/14017430601049365","article-title":"Management of hepatitis C among drug users attending general practice in Ireland: Baseline data from the Dublin area hepatitis C in general practice initiative","volume":"13","author":"Cullen","year":"2007","journal-title":"European Journal of General Practice"},{"issue":"3","key":"10.1016\/j.drugpo.2017.05.045_bib0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","article-title":"Self-report among injecting drug users: A review","volume":"51","author":"Darke","year":"1998","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.drugpo.2017.05.045_bib0060","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/hep.25556","article-title":"Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001\u20132008","volume":"55","author":"Denniston","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0065","series-title":"HIV Prevention Program","author":"Department for Public Health","year":"2015"},{"issue":"48","key":"10.1016\/j.drugpo.2017.05.045_bib0070","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.15585\/mmwr.mm6448a3","article-title":"Syringe service programs for persons who inject drugs in urban, suburban, and rural areas\u2014United States, 2013","volume":"64","author":"Des Jarlais","year":"2015","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"5","key":"10.1016\/j.drugpo.2017.05.045_bib0075","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-3999(00)00155-0","article-title":"Depression, fatigue, and functional disability in patients with chronic hepatitis C","volume":"49","author":"Dwight","year":"2000","journal-title":"Journal of Psychosomatic Research"},{"issue":"2","key":"10.1016\/j.drugpo.2017.05.045_bib0080","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/gast.2002.34750","article-title":"Psychiatric disorders among veterans with hepatitis C infection","volume":"123","author":"el-Serag","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0085","unstructured":"Environmental Systems Research Institute, (2010). ESRI Data and Maps 10 (StreetMap North America). Redlands, CA"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0090","doi-asserted-by":"crossref","first-page":"S286","DOI":"10.1086\/427442","article-title":"Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): The importance of routine mental health screening as a component of a comanagement model of care","volume":"5","author":"Fireman","year":"2005","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0095","series-title":"U.S., uninsured rate sinks to 13.4% in second quarter","author":"Gallup Well-Being","year":"2014"},{"issue":"6","key":"10.1016\/j.drugpo.2017.05.045_bib0100","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.genhosppsych.2005.06.006","article-title":"Depression and anxiety in patients with hepatitis C: Prevalence, detection rates and risk factors","volume":"27","author":"Golden","year":"2005","journal-title":"General Hospital Psychiatry"},{"issue":"2","key":"10.1016\/j.drugpo.2017.05.045_bib0105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/add.13197","article-title":"Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: The ETHOS study","volume":"111","author":"Grebely","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2014.01.002","article-title":"Can hepatitis C virus infection be eradicated in people who inject drugs?","volume":"104","author":"Grebely","year":"2014","journal-title":"Antiviral Research"},{"issue":"5","key":"10.1016\/j.drugpo.2017.05.045_bib0115","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.drugpo.2007.01.009","article-title":"Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection","volume":"18","author":"Grebely","year":"2007","journal-title":"International Journal on Drug Policy"},{"issue":"1\u20132","key":"10.1016\/j.drugpo.2017.05.045_bib0120","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drugalcdep.2007.09.008","article-title":"Barriers associated with the treatment of hepatitis C virus infection among illicit drug users","volume":"93","author":"Grebely","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.drugpo.2017.05.045_bib0125","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MEG.0b013e32832a8c4c","article-title":"Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: A novel model incorporating multidisciplinary care and peer support","volume":"22","author":"Grebely","year":"2010","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"5","key":"10.1016\/j.drugpo.2017.05.045_bib0130","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2893.2009.01080.x","article-title":"Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents","volume":"16","author":"Grebely","year":"2009","journal-title":"Journal of Viral Hepatitis"},{"issue":"10","key":"10.1016\/j.drugpo.2017.05.045_bib0135","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.drugpo.2015.07.005","article-title":"Recommendations for the management of hepatitis C virus infection among people who inject drugs","volume":"26","author":"Grebely","year":"2015","journal-title":"International Journal on Drug Policy"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.045_bib0140","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.2105\/AJPH.2012.300874","article-title":"Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users","volume":"103","author":"Havens","year":"2013","journal-title":"American Journal of Public Health"},{"issue":"2","key":"10.1016\/j.drugpo.2017.05.045_bib0145","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2307\/3096941","article-title":"Respondent-driven sampling: A new approach to the study of hidden populations","volume":"44","author":"Heckathorn","year":"1997","journal-title":"Social Problems"},{"issue":"2","key":"10.1016\/j.drugpo.2017.05.045_bib0150","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1053\/j.gastro.2007.11.039","article-title":"Daily cannabis use: A novel risk factor of steatosis severity in patients with chronic hepatitis C","volume":"134","author":"Hezode","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0155","series-title":"Applied logistic regression","author":"Hosmer","year":"1989"},{"issue":"2","key":"10.1016\/j.drugpo.2017.05.045_bib0160","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0738-3991(01)00134-3","article-title":"Internet access and Internet use for health information among people living with HIV-AIDS","volume":"46","author":"Kalichman","year":"2002","journal-title":"Patient Education and Counseling"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0165","series-title":"Sale and disposal of hypodermic syringes or needles, KRS 217.177","author":"Kentucky Legislative Research Commission","year":"2005"},{"issue":"1\u20132","key":"10.1016\/j.drugpo.2017.05.045_bib0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0376-8716(97)01339-2","article-title":"Reliability of drug dependents\u2019 self-reports","volume":"45","author":"Kokkevi","year":"1997","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0175","series-title":"Program evaluation of the appalachian regional commission\u2019s telecommunications and technology projects: FY 2004-FY 2010","author":"Lawrence","year":"2015"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2017.02.014","article-title":"Current therapy for chronic hepatitis C: The role of direct-acting antivirals","author":"Li","year":"2017","journal-title":"Antiviral Research"},{"issue":"9859","key":"10.1016\/j.drugpo.2017.05.045_bib0185","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: A systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lim","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.drugpo.2017.05.045_bib0190","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/0003-4819-156-4-201202210-00004","article-title":"The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007","volume":"156","author":"Ly","year":"2012","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0195","article-title":"Characteristics of patients seeking health information online via social health networks versus general Internet sites: A comparative study","author":"Magnezi","year":"2014","journal-title":"Informatics for Health and Social Care"},{"issue":"4","key":"10.1016\/j.drugpo.2017.05.045_bib0200","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jhep.2008.01.004","article-title":"Environmental factors as disease accelerators during chronic hepatitis C","volume":"48","author":"Mallat","year":"2008","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1016\/j.drugpo.2017.05.045_bib0205","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/hep.26431","article-title":"Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals","volume":"58","author":"Martin","year":"2013","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.drugpo.2017.05.045_bib0210","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.2105\/AJPH.2013.301458","article-title":"A randomized trial of a hepatitis care coordination model in methadone maintenance treatment","volume":"103","author":"Masson","year":"2013","journal-title":"Am J Public Health"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0215","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.amjmed.2013.01.031","article-title":"Half a diagnosis: Gap in confirming infection among hepatitis C antibody-positive patients","volume":"8","author":"McGibbon","year":"2013","journal-title":"American Journal of Medicine"},{"issue":"4","key":"10.1016\/j.drugpo.2017.05.045_bib0220","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/hep.26246","article-title":"A global view of hepatitis C: Physician knowledge, opinions, and perceived barriers to care","volume":"57","author":"McGowan","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.drugpo.2017.05.045_bib0225","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10900-007-9083-3","article-title":"Limited uptake of hepatitis C treatment among injection drug users","volume":"33","author":"Mehta","year":"2008","journal-title":"Journal of Community Health"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.045_bib0230","doi-asserted-by":"crossref","first-page":"e8340","DOI":"10.5812\/hepatmon.8340","article-title":"Neuropsychiatric and psychosocial issues of patients with hepatitis C infection: A selective literature review","volume":"13","author":"Modabbernia","year":"2013","journal-title":"Hepatitis Monthly"},{"issue":"5","key":"10.1016\/j.drugpo.2017.05.045_bib0235","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.socscimed.2007.11.044","article-title":"Socioeconomic context, distance to primary care and detection of hepatitis C: A French population-based study","volume":"66","author":"Monnet","year":"2008","journal-title":"Social Science & Medicine"},{"issue":"8","key":"10.1016\/j.drugpo.2017.05.045_bib0240","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1525-1497.2005.0161.x","article-title":"Barriers to the treatment of hepatitis C. Patient, provider, and system factors","volume":"20","author":"Morrill","year":"2005","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0245","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2147\/PPA.S49113","article-title":"Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: A literature review","volume":"7","author":"Mravcik","year":"2013","journal-title":"Patient Prefer Adherence"},{"issue":"9791","key":"10.1016\/j.drugpo.2017.05.045_bib0250","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"The Lancet"},{"issue":"5","key":"10.1016\/j.drugpo.2017.05.045_bib0255","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.drugpo.2007.01.007","article-title":"Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: Insights from the ATAHC study","volume":"18","author":"Nguyen","year":"2007","journal-title":"International Journal on Drug Policy"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0260","series-title":"Chronic disease and the internet","author":"Pew Internet & American Life Project","year":"2010"},{"issue":"2","key":"10.1016\/j.drugpo.2017.05.045_bib0265","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/nrgastro.2015.227","article-title":"HCV in 2015: Advances in hepatitis C research and treatment","volume":"13","author":"Rehermann","year":"2016","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"issue":"Suppl. 20","key":"10.1016\/j.drugpo.2017.05.045_bib0270","first-page":"20","article-title":"The mini-international neuropsychiatric interview (M. I. N. I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.drugpo.2017.05.045_bib0275","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3102\/10769986018002155","article-title":"It\u2019s about time: Using discrete-time survival analysis to study duration and the timing of events","volume":"18","author":"Singer","year":"1993","journal-title":"Journal of Educational and Behavioral Statistics"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0280","series-title":"Applied longitudinal data analysis: Modeling change and event occurrence","author":"Singer","year":"2003"},{"issue":"RR-4","key":"10.1016\/j.drugpo.2017.05.045_bib0285","first-page":"1","article-title":"Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945\u20131965","volume":"61","author":"Smith","year":"2012","journal-title":"MMWR Recommendations and Reports"},{"issue":"7","key":"10.1016\/j.drugpo.2017.05.045_bib0290","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1093\/cid\/ciu509","article-title":"Trends in HCV RNA testing among HCV antibody positive persons in care, 2003\u20132010","volume":"59","author":"Spradling","year":"2014","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0295","unstructured":"Stensland, J,M.C., Sutton, J. (2002). An Analysis of the Financial Conditions of Health Care Institutions in the Appalachian Region and their Economic Impacts. Washington DC."},{"issue":"3","key":"10.1016\/j.drugpo.2017.05.045_bib0300","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.24131","article-title":"Insurance status and treatment candidacy of hepatitis C patients: Analysis of population-based data from the United States","volume":"53","author":"Stepanova","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0305","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2296-8-47","article-title":"Information from the internet and the doctor-patient relationship: The patient perspective\u2014a qualitative study","volume":"8","author":"Stevenson","year":"2007","journal-title":"BMC Family Practice"},{"issue":"1","key":"10.1016\/j.drugpo.2017.05.045_bib0310","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.drugalcdep.2004.07.002","article-title":"The impact of injecting drug use status on hepatitis C-related referral and treatment","volume":"77","author":"Stoove","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"Suppl. 5","key":"10.1016\/j.drugpo.2017.05.045_bib0315","doi-asserted-by":"crossref","first-page":"S304","DOI":"10.1086\/427445","article-title":"Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users","volume":"40","author":"Strathdee","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1016\/j.drugpo.2017.05.045_bib0320","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0376-8716(02)00010-8","article-title":"Treating hepatitis C in methadone maintenance patients: An interim analysis","volume":"67","author":"Sylvestre","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"issue":"10","key":"10.1016\/j.drugpo.2017.05.045_bib0325","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/01.meg.0000216934.22114.51","article-title":"Cannabis use improves retention and virological outcomes in patients treated for hepatitis C","volume":"18","author":"Sylvestre","year":"2006","journal-title":"European Journal of Gastroenterology and Hepatology"},{"issue":"7","key":"10.1016\/j.drugpo.2017.05.045_bib0330","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1465-3362.2012.00468.x","article-title":"Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs","volume":"31","author":"Treloar","year":"2012","journal-title":"Drug and Alcohol Review"},{"issue":"12","key":"10.1016\/j.drugpo.2017.05.045_bib0335","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1365-2893.2009.01250.x","article-title":"Uptake and delivery of hepatitis C treatment in opiate substitution treatment: Perceptions of clients and health professionals","volume":"17","author":"Treloar","year":"2010","journal-title":"Journal of Viral Hepatitis"},{"issue":"3","key":"10.1016\/j.drugpo.2017.05.045_bib0340","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/01.PHH.0000267684.23529.2c","article-title":"Benefits and adverse effects of hepatitis C screening: Early results of a screening program","volume":"13","author":"Trepka","year":"2007","journal-title":"Journal of Public Health Management and Practice"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0345","series-title":"Profiles of Affordable Care Act coverage expansion enrollment for medicaid\/CHIP and the health insurance marketplace, 10-1-2013 to 3-31-2014","author":"U.S. Department of Health and Human Services","year":"2014"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0350","series-title":"Home access\u00ae hepatitis C check and hepatitis C check express summary of safety and effectivess","author":"US Food and Drug Administration","year":"1999"},{"key":"10.1016\/j.drugpo.2017.05.045_bib0355","series-title":"Respondent-driven sampling analysis tool (RDSAT) version 7.1","author":"Volz","year":"2012"},{"issue":"7","key":"10.1016\/j.drugpo.2017.05.045_bib0360","doi-asserted-by":"crossref","first-page":"e103345","DOI":"10.1371\/journal.pone.0103345","article-title":"Hepatitis C virus infection epidemiology among people who inject drugs in Europe: A systematic review of data for scaling up treatment and prevention","volume":"9","author":"Wiessing","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.drugpo.2017.05.045_bib0365","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1017\/S0950268812000696","article-title":"Social networks and HCV viraemia in anti-HCV-positive rural drug users","volume":"141","author":"Young","year":"2013","journal-title":"Epidemiology and Infection"},{"issue":"17","key":"10.1016\/j.drugpo.2017.05.045_bib0370","first-page":"453","article-title":"Increases in hepatitis C virus infection related to injection drug use among persons aged <\/=30years\u2014Kentucky, Tennessee, Virginia, and West Virginia, 2006\u20132012","volume":"64","author":"Zibbell","year":"2015","journal-title":"MMWR Morbidity and Mortality Weekly Report"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917301494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395917301494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T09:22:36Z","timestamp":1535707356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395917301494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":74,"alternative-id":["S0955395917301494"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.05.045","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Healthcare contact and treatment uptake following hepatitis C virus screening and counseling among rural Appalachian people who use drugs","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2017.05.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}